-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
News
-
USPTO Toolkit Now Available for Those New to PTAB Proceedings
January 17, 2020
The US Patent and Trademark Office on January 15, 2020, released a “New to PTAB” toolkit now available on the PTAB webpage of the USPTO website. -
EU Report Highlights States of IP Protection in ‘Third Countries’
January 16, 2020
“A low level of protection for trade secrets and IP theft in a number of countries, notably in China and India” have caused “irreparable harm to European businesses” said the European Commission, the executive branch of the European Union, in its “Report on the protection and enforcement of intellectual property rights in third countries” released on January 8, 2020. -
AIPLA Argues That A Generic Term Combined With a gTLD Can Create a Protectable Trademark
January 15, 2020
The addition of a generic top-level domain (gTLD) to an otherwise generic term can, under certain circumstances, create a protectable trademark, the American Intellectual Property Law Association said in an amicus brief filed with the Supreme Court on January 13, 2020. -
Fifth Circuit Nixes Statutory Damages Award in Hospital Form Copyright Clash
January 14, 2020
The US Court of Appeals for the Fifth Circuit on January 9, 2020, held that statutory damage awards are not available when a defendant infringes in one way before the copyright was registered and another way after registration. -
Amgen Wins in Kidney Drug Infringement Appeal
January 10, 2020
The US Court of Appeals for the Federal Circuit on January 7, 2020, vacated and remanded a lower court ruling which held that Amneal Pharmaceuticals LLC, an integrated specialty pharmaceutical company, didn’t infringe Amgen Inc.’s patent for the kidney disease drug Sensipar.